Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/31067
Title: Eliminating viral hepatitis C in Belgium: the micro-elimination approach
Authors: BUSSCHOTS, Dana 
Toghanian, Samira
BIELEN, Rob 
Salomonsson, Stina
KOC, Ozgur 
Hendrickx, Greet
Jadoul, Michel
Nevens, Frederik
Sokal, Etienne
Brixko, Christian
Peerlinck, Kathelijne
Apers, Ludwig
ROBAEYS, Geert 
Lazarus, Jeffrey V.
Issue Date: 2020
Publisher: BMC
Source: BMC INFECTIOUS DISEASES, 20 (Art N° 181)
Abstract: BackgroundHepatitis C virus is one of the leading causes of chronic liver disease and liver-related deaths worldwide. The estimated prevalence of chronic hepatitis C viral infection among the general Belgian population was 0.57% (n=64,000) in 2015. Although Belgium has had a 'Hepatitis C Plan' since 2014, elimination efforts are unclear. This study employs the best available data and modelling estimates to define the burden of hepatitis C viral infection among key subgroups in Belgium, identify information gaps and propose potential approaches to screening, linkage to care and treatment, and cure.MethodsWe examined the peer-reviewed and grey literature since 2012 for data on the prevalence of hepatitis C viral infection in Belgium in key subgroups identified by national experts and in the literature. Ultimately, this research is primarily based on data provided by the key stakeholders themselves due to a lack of reliable data in the literature. Based on this, we modelled the treatment rates required to reach elimination of hepatitis C in several subgroups.ResultsEleven potential subgroups were identified. There were no data available for two subgroups: generational cohorts and men who have sex with men. In six subgroups, fewer than 3000 people were reported or estimated to have hepatitis C infection. Migrants and people who inject drugs were the most affected subgroups, and children were the least affected subgroup. Only two subgroups are on target to achieve elimination by 2030: patients living with haemophilia and transplant recipients.ConclusionsRemoving Belgian treatment reimbursement restrictions in January 2019 was a big step towards eliminating HCV. In addition, increasing surveillance, including with a national registry, treatment prescription by other health-care providers and availability of treatment in local pharmacies are central to improving the current situation and getting on track to reach the 2030 WHO hepatitis C elimination targets in Belgium.
Notes: Lazarus, JV (reprint author), Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain.
Jeffrey.lazarus@isglobal.org
Other: Lazarus, JV (reprint author), Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain. Jeffrey.lazarus@isglobal.org
Keywords: Disease elimination;Health policy;Hepatitis C;Treatment;Belgium
Document URI: http://hdl.handle.net/1942/31067
e-ISSN: 1471-2334
DOI: 10.1186/s12879-020-4898-y
ISI #: WOS:000520583600003
Rights: The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Category: A1
Type: Journal Contribution
Validations: ecoom 2021
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
dana.pdfPublished version655.23 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

11
checked on Apr 30, 2024

Page view(s)

26
checked on Jun 22, 2022

Download(s)

4
checked on Jun 22, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.